92 related articles for article (PubMed ID: 1705248)
1. [Preoperative autologous blood donation, effect of hydroxyethyl starch on the reticuloendothelial system and opsonins].
Lackner FX; Graninger W; Ilias W; Panzer S; Schulz E
Infusionstherapie; 1990 Oct; 17(5):276-9. PubMed ID: 1705248
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
Khosropour R; Graninger W; Lackner F
Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
4. [Effect of hydroxyethyl starch, oxypolygelatin and human albumin on the phagocytic function of the reticuloendothelial system in healthy subjects].
Lenz G; Hempel V; Junger H; Werle H; Buckenmaier P
Anaesthesist; 1986 Jul; 35(7):423-8. PubMed ID: 2428269
[TBL] [Abstract][Full Text] [Related]
5. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
6. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hemodilution on systemic and capillary hematocrit].
Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
[TBL] [Abstract][Full Text] [Related]
8. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
[TBL] [Abstract][Full Text] [Related]
9. [Autotransfusion with leap-frog technique in patients with coronary heart disease and planned aortocoronary venous bypass].
Kiesewetter H; Jung F; Pindur G; Koscielny J; Jakobs K; Wenzel E
Infusionsther Transfusionsmed; 1994 Apr; 21(2):96-103. PubMed ID: 7517239
[TBL] [Abstract][Full Text] [Related]
10. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
11. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
12. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of autologous transfusion procedures in hip surgery].
Lorentz A; Osswald PM; Schilling M; Jani L
Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
[TBL] [Abstract][Full Text] [Related]
15. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis.
Shatney CH; Chaudry IH
Circ Shock; 1984; 13(1):21-6. PubMed ID: 6202435
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the phagocytic inhibition of the rat reticuloendothelial system and the anticholinesterasic effect of an insecticide, Carbaryl (author's transl)].
Pipy B; Beraud M; Gaillard D
J Physiol (Paris); 1978; 74(4):379-85. PubMed ID: 105127
[TBL] [Abstract][Full Text] [Related]
18. The effect of acute normovolemic hemodilution and acute hypervolemic hemodilution on coagulation and allogeneic transfusion.
Saricaoglu F; Akinci SB; Celiker V; Aypar U
Saudi Med J; 2005 May; 26(5):792-8. PubMed ID: 15951872
[TBL] [Abstract][Full Text] [Related]
19. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
20. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
